I am Jeffrey Weber, a medical oncologist at the Laura and Isaac Perlmutter Cancer Center at NYU Langone Health in New York City.
Archive | Clinical Trials
CheckMate 204 Update: Practice-Changing for Brain Metastases?
Posted in Melanoma News, Health Professionals, Clinical Trials
ONCOS-102, Keytruda Combo May Reduce Tumor Size in Treatment-resistant Melanoma, Early Trial Data Show
Melanoma patients who become resistant to immune checkpoint inhibitors may regain susceptibility to such treatments after receiving Targovax‘s immune activator ONCOS-102, early clinical trial findings suggest.
Posted in Melanoma News, Health Professionals, Clinical Trials
A prospective trial of adjuvant therapy for high-risk uveal melanoma: Assessing 5-year survival outcomes
Because survival after diagnosis of uveal melanoma metastasis is poor, researchers conducted an adjuvant trial of sequential, low-dose dacarbazine (DTIC) and interferon-alpha-2b (IFN-??2b) in patients with cytogenetic high-risk uveal melanoma.
Posted in Melanoma News, Health Professionals, Clinical Trials
Standardization Arrives for Neoadjuvant Trials in Melanoma
The International Neoadjuvant Melanoma Consortium (INMC) recently published a comprehensive set of recommendations for the design and implementation of clinical trials that aim to assess neoadjuvant therapy in high-risk resectable melanoma patients in Lancet Oncology.
Posted in Melanoma News, Health Professionals, Clinical Trials
